A street interview clip from the weight loss provider, putting questions about weight loss medication to people in Liverpool. Short, promotional and light on detail.
Recap by typeshit. Video by @my_bmi_ on TikTok.
A sponsored-style explainer that walks through semaglutide versus tirzepatide and the post-shortage compounding limits, while featuring telehealth company Mochi Health.
ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.
18:51
A doctor walks through four of the most talked about weight loss drugs in one overview, covering the big names people ask about most.
Investseekers shares notes on the upcoming French rollout of the Wegovy pill and where Novo Nordisk might launch it next in Europe.
The Indore maker wants a drug company to license the formula. It admits the combination has never been tested alongside a GLP-1 drug.
In the 308-person REMAIN-1 study, Revita patients held onto about 80% of their lost weight versus 67% with sham. Fractyl plans an FDA filing in late 2026.
Loading…